Taysha Gene Therapies: Q4 Earnings Insights

Taysha Gene Therapies TSHA reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Taysha Gene Therapies beat estimated earnings by 936.0%, reporting an EPS of $0.92 versus an estimate of $-0.11.

Revenue was up $1.10 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.76 which was followed by a 26.0% increase in the share price the next day.

Here's a look at Taysha Gene Therapies's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.17 -0.31 -0.35 -0.33
EPS Actual -0.93 -0.38 -0.28 -0.34
Revenue Estimate 1.40M 2.00M 70K 8.18M
Revenue Actual 4.75M 2.40M 4.71M 2.50M

To track all earnings releases for Taysha Gene Therapies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!